Introduction

As severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that causes COVID‐19, is highly infectious and variable, and given that we now understand a large proportion of asymptomatic carriers can be still infectious [1], it is expected that a normalization of epidemic prevention and control measures will be required for a long time worldwide. Our neurology department at Xuanwu Hospital in Beijing is one of the national centers for the research and treatment of neurological disorders in China. Since healthcare settings are at a high risk of virus dissemination, we have implemented timely strategies to reduce cross‐infection and protect our patients and staff to avoid critically overloading our system as a result of a sudden decrease in staff because of quarantining or isolation [2]. Moreover, having made it through several months of this crisis, it is now clear to us that the pattern of clinical practice and research at our hospital has already undergone major changes, many of which are very likely to persist well into the future. In the present paper, we summarize our experiences in adapting neurological practice during the COVID‐19 outbreak and post‐pandemic era, and we discuss how our experiences are helping us think about and meet some unsolved problems and challenges.